Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By stimulating these receptors, https://emiliacioi963572.bloggazzo.com/35121159/tirzepatide-a-promising-new-treatment-for-obesity